Starling Oncology, Inc.
$6.43
-0.48 (-6.95%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -3.0%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -12.3%
Own STLN?
See how STLN contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.